AMSTERDAM (Reuters) - The European Medicines Agency (EMA) said on Monday it would no longer post ... as it decided on the use of vaccines in the European Union. The European Commission and other EU ...

Heads of R&D at all major pharma companies have come together to express their concerns about severe disruption to the European Medicines Agency (EMA ... the European Union by 2019 means that ...

The EMA anticipates that the ability to access scientific advice will foster innovation among medical device manufacturers.

Bio-Thera Solutions Inc. (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of innovative ...

Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...

The approval is based on positive results from the Phase 3 ATTRibute-CM study, in which acoramidis demonstrated the most rapid benefit seen in ...

The European Medicines Agency (EMA) announced on Monday that it will be discontinuing its presence on X, opting instead to utilize rival platform Bluesky.

A crackdown on the sale of counterfeit medicines online, coordinated by Europol, has resulted in the seizure of items worth ...

Imfinzi has been recommended for approval in the European Union, EU, as monotherapy for the treatment of adults with ...

Imfinzi recommended for approval in European Union for the treat of adults with limited-stage small cell lung cancer ...

AMSTERDAM, Jan 27 (Reuters) - The European Medicines Agency (EMA) said on Monday it ... as it decided on the use of vaccines in the European Union. The European Commission and other EU ...